4//SEC Filing
Shih Alvin 4
Accession 0001437749-24-003020
CIK 0001434647other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:08 PM ET
Size
6.0 KB
Accession
0001437749-24-003020
Insider Transaction Report
Form 4
Shih Alvin
Director
Transactions
- Award
Stock Option (right to buy)
2024-01-20+58,800→ 58,800 totalExercise: $5.72Exp: 2034-01-19→ Common Stock (58,800 underlying)
Footnotes (2)
- [F1]The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, January 19, 2024.
- [F2]Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 33.33% of the shares will vest on January 20, 2025 and the remaining 66.67% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.
Documents
Issuer
ZEVRA THERAPEUTICS, INC.
CIK 0001434647
Entity typeother
Related Parties
1- filerCIK 0001610064
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 8:08 PM ET
- Size
- 6.0 KB